. Second-generation antipsychotics did not improve outcomes and increased costs for patients with Alzheimer disease and psychosis. ACP J Club. 2008 Mar-Apr;148(2):53. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments